Czynniki ryzyka i podtypy kliniczne padaczki wtórnej i opornej na leki u dzieci z heterotopią substancji szarej
Risk factors and clinical phenotype stratification of secondary and drug-resistant epilepsy in children with gray matter heterotopia
W skrócie
Badanie dotyczyło dzieci z wrodzoną wadą mózgu zwaną heterotopią substancji szarej, która może prowadzić do padaczki. Naukowcy zbadali 219 dzieci i odkryli, że niektóre cechy - takie jak zaburzenia rozwoju, opóźnienia intelektualne i inne anomalie mózgu - zwiększają ryzyko zachorowania na padaczkę, która nie reaguje na leki. Wyniki pozwalają lekarzom wcześniej rozpoznać dzieci z wyższym ryzykiem i zastosować lepsze leczenie.
Oryginalny abstract (angielski)
BACKGROUND: Gray matter heterotopia (GMH) is a congenital brain malformation caused by abnormal neuronal migration, and children with GMH are at risk of secondary epilepsy and drug-resistant epilepsy (DRE). We aim to investigate risk factors for secondary and DRE in children with GMH for early risk identification and management. METHODS: This retrospective study enrolled children with GMH diagnosed using magnetic resonance imaging at Chongqing Medical University Children's Hospital (from Sept 2012 to Sept 2025). Kaplan-Meier analysis, Firth-corrected Cox regression, and least absolute shrinkage and selection operator-Cox (LASSO-Cox) analysis were used to identify risk factors for secondary epilepsy. Firth-LASSO logistic regression was used to assess risk factors of DRE. K-mode clustering was used to define phenotypic subgroups based on pre-epilepsy baseline variables. RESULTS: A total of 219 children with GMH were enrolled in this study. Periventricular nodular heterotopia was the most common type of GMH (82.19%). The main clinical manifestations included epileptic seizures (43.38%), intellectual disability (ID) (38.81%), and global developmental delay (GDD) (33.33%). Kaplan-Meier analysis showed that ID (P < 0.001), GDD (P < 0.001), multiple brain abnormalities, and patent foramen ovale (PFO) (P = 0.006) were linked to shorter seizure-free survival. Multivariate Firth-corrected Cox regression identified ID [hazard ratio (HR) = 2.606, 95% confidence interval (95% CI) = 1.375-4.864, P = 0.003], GDD (HR = 3.068, 95% CI 1.625-5.912, P < 0.001), lissencephaly-pachygyria spectrum (HR = 1.835, 95% CI 1.046-3.139, P = 0.035), and PFO (HR = 4.002, 95% CI 1.659-8.433, P = 0.003) as being statistically associated with secondary epilepsy. Exploratory mediation analysis demonstrated that multiple structural abnormalities were significantly associated with both ID and epilepsy. Furthermore, subcortical band heterotopia [odds ratio (OR) = 6.229, 95% CI 1.596-25.797, P = 0.008] and moderate-to-severe ID (OR = 6.114, 95% CI 2.136-20.855, P < 0.001) were statistically associated with secondary DRE. Cluster analysis stratified patients into high-risk (n = 78) and low-risk (n = 141) subgroups. Permutational multivariate analysis of variance revealed significant differences in characteristics between the two groups (F = 40.494, R = 0.157, P = 0.001). CONCLUSIONS: Developmental impairment, lissencephaly-pachygyria spectrum, and SBH were associated with higher risks of epilepsy and DRE. In addition, an exploratory phenotype stratification into high and low risk of secondary epilepsy based on clinical and imaging features is proposed. Prospective multicenter studies are needed to validate these findings and advance precision care for children with GMH.